The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

It’s notoriously tough to land a political blow on Donald Trump, but California congressman Ro Khanna is one of the few ...

Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force ...

Veracyte, Inc. , a leading genomic diagnostics company, today announced the publication of two studies demonstrating the Afirma GRID (Genomic Resource for Intelligent Discovery) research tool's ...

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring ...

Health Affairs' Rob Lott interviews Michael T. Osterholm, the director of the Center for Infectious Disease Research and ...

Company delivers record quarterly revenue, meets or exceeds all guidance metricsFull year 2025 earnings outlook raisedMIAMI, Nov. 04, 2025 ...

The major stock indexes were mixed on Monday, at the outset of another busy week of quarterly earnings reports and the release of key private sector employment data.

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase ...